Abstract: A high-coercivity neodymium-cerium-iron-boron permanent magnet has at least one of the following features: the area of grain boundary RE-rich phases in the magnet accounts for 4% or more of the area of a whole field of view; the grain boundary RE-rich phases in the magnet are fine and uniformly distributed; and the mean value of ratios of the area of block-shaped grain boundary RE-rich phases located at intersections of three or more main-phase grains to the total area of all the three or more adjacent main-phase grains in the vicinity is less than or equal to 30%. RE-rich phases in the magnet are continuously distributed along grain boundaries, thereby increasing the depth of diffusion of a diffusion source into the magnet, improve the uniformity of distribution of the diffusion source in the, and thus further improving the magnetic performance of the diffusion magnet.

Abstract: This disclosure relates to a method of preventing end stage renal disease using an angiotensin II antagonist in patients with impaired renal function. Angiotensin II antagonists such as candesartan cilexetil, eprosartan, irbesartan, losartan, tasosartan, telmisartan, valsartan, 2-butyl-4-chloro-1-[(2′-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazolecarboxylic acid and 3-(2′-(tetrazol-5-yl)-1,1′-biphen-4-yl)methyl-5,7-dimethyl-2-ethyl-3H-imidazo[4,5-b]pyridine, or pharmaceutically acceptable salts thereof are useful.